yohimbine and cadmium
yohimbine has been researched along with cadmium in 7 studies
Research
Studies (7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Briggs, GM; Gwathmey, JK; Morgan, JP; Slawsky, MT | 1 |
| Fredholm, BB; Hu, PS | 1 |
| Rafuse, PE; Smith, PA | 1 |
| Crepel, F; Debono, M; Flores, R | 1 |
| Limberger, N; Späth, L; Starke, K | 1 |
| Foguet, M; Lübbert, H; Parekh, AB; Stühmer, W | 1 |
| Azad, SC; DeBock, F; Hapfelmeier, G; Kurz, J; Parsons, CG; Rammes, G; Zieglgänsberger, W | 1 |
Other Studies
7 other study(ies) available for yohimbine and cadmium
| Article | Year |
|---|---|
Role of intracellular sodium in the regulation of intracellular calcium and contractility. Effects of DPI 201-106 on excitation-contraction coupling in human ventricular myocardium.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Aequorin; Algorithms; Cadmium; Calcium; Heart; Humans; Myocardial Contraction; Piperazines; Ryanodine; Sodium; Tetrodotoxin; Veratridine; Yohimbine | 1988 |
Alpha 2-adrenoceptor agonist-mediated inhibition of [3H]noradrenaline release from rat hippocampus is reduced by 4-aminopyridine, but that caused by an adenosine analogue or omega-conotoxin is not.
Topics: 4-Aminopyridine; Adenosine; Adrenergic alpha-Agonists; Aminopyridines; Animals; Brimonidine Tartrate; Cadmium; Cadmium Chloride; Conotoxins; Hippocampus; Male; Mollusk Venoms; Norepinephrine; Phenylisopropyladenosine; Quinoxalines; Rats; Rats, Inbred Strains; Yohimbine | 1989 |
Alpha 2-adrenergic hyperpolarization is not involved in slow synaptic inhibition in amphibian sympathetic ganglia.
Topics: Adrenergic alpha-Agonists; Animals; Cadmium; Desipramine; Epinephrine; Ganglia, Sympathetic; In Vitro Techniques; Membrane Potentials; Methacholine Chloride; Methacholine Compounds; Rana pipiens; Receptors, Adrenergic, alpha; Synapses; Yohimbine | 1986 |
Alpha-adrenergic inhibition of rat cerebellar Purkinje cells in vitro: a voltage-clamp study.
Topics: Adrenergic alpha-Agonists; Animals; Cadmium; Calcium; Calcium Channel Blockers; Cerebellum; Clonidine; Electric Conductivity; Membrane Potentials; Phentolamine; Prazosin; Purkinje Cells; Rats; Tetrodotoxin; Yohimbine | 1987 |
Presynaptic alpha 2-adrenoceptor, opioid kappa-receptor and adenosine A1-receptor interactions on noradrenaline release in rabbit brain cortex.
Topics: Analgesics, Opioid; Animals; Cadmium; Cerebral Cortex; Clonidine; Cocaine; Cyclazocine; Drug Interactions; Electric Stimulation; Ethylketocyclazocine; Female; In Vitro Techniques; Male; Norepinephrine; Phenylisopropyladenosine; Rabbits; Receptors, Adrenergic, alpha; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Purinergic; Tetrodotoxin; Yohimbine | 1988 |
Ca2+ oscillations and Ca2+ influx in Xenopus oocytes expressing a novel 5-hydroxytryptamine receptor.
Topics: Animals; Cadmium; Caffeine; Calcium; Cell Membrane; Chloride Channels; Electrophysiology; GTP-Binding Proteins; Heparin; Inosine Triphosphate; Microinjections; Oocytes; Receptors, Serotonin; RNA, Complementary; Serotonin; Xenopus; Yohimbine | 1993 |
Alpha2-adrenoreceptor activation inhibits LTP and LTD in the basolateral amygdala: involvement of Gi/o-protein-mediated modulation of Ca2+-channels and inwardly rectifying K+-channels in LTD.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclase Inhibitors; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Amygdala; Animals; Barium; Cadmium; Calcium Channel Blockers; Calcium Channels; Clonidine; Colforsin; Cyclic Nucleotide Phosphodiesterases, Type 4; Electric Stimulation; Enzyme Inhibitors; Excitatory Postsynaptic Potentials; Heterotrimeric GTP-Binding Proteins; Imines; In Vitro Techniques; Isoquinolines; Long-Term Potentiation; Long-Term Synaptic Depression; Membrane Potentials; Mice; Norepinephrine; omega-Agatoxin IVA; omega-Conotoxins; Patch-Clamp Techniques; Pertussis Toxin; Piperazines; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Pyridines; Receptors, Adrenergic, alpha-2; Serotonin Antagonists; Sulfonamides; Yohimbine | 2003 |